Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in NF-1 Plexiform Neurofibromas
NCT01402817Phase 2Terminated
- Sponsor
- Indiana University
- Start
- Mar 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in neurofibromatosis type 1 (NF1), plexiform neurofibroma (PN), sponsored by Indiana University. Started Mar 2012; status: terminated.
02
Drugs
sunitinib
03
Conditions
neurofibromatosis type 1 (NF1)plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT01402817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402817.